Also published in GlobeNewswire:
Rand Logistics Announces Organizational and Corporate Governance Changes
x hide permanently

BioXcel Therapeutics Appoints June Bray to Board of Directors


NEW HAVEN, Conn., March 01, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. ("BioXcel" or the "Company") (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced the appointment of June Bray to its Board of Directors...

Mentions: Nasdaq artificial intelligence Board